NIH-funded research R01 grant

Spatial circuits in the prefrontal cortex that control fear and discrimination

Official title: Spatially-organized prefrontal circuits regulating fear expression and discrimination

Funded at University of Pittsburgh at Pittsburgh · NIH-11448740 · Data updated 2026-11-12

Researchers are exploring how different parts of the prefrontal cortex help decide when to feel fear or not, with the goal of better understanding anxiety-related conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$705,236
NIH project number1R01MH142649-01A1
Project IDNIH-11448740 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients with anxiety or trauma-related disorders that involve exaggerated fear responses, who may benefit from future translation of these findings.

Less likely to help

Healthy individuals or those without fear-related disorders may not directly benefit from this basic science study.

What this research studies

This project looks at how the mouse prefrontal cortex communicates with brain regions like the amygdala and PAG to regulate fear responses. By using advanced imaging, the study aims to map where neurons respond to threats versus safe cues and how these signals influence behavior. The goal is to uncover how specific neural pathways differentiate fear to threats from non-threats, which could inform future treatments for anxiety and trauma-related disorders.

Why it matters

Potential benefit: Findings could lead to new approaches for reducing inappropriate fear responses in anxiety and trauma-related conditions.

How similar studies have gone: Previous animal studies show spatial organization in fear circuits, supporting the plausibility of this approach.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Stujenske, Joseph Matthew — University of Pittsburgh at Pittsburgh
  • Study coordinator: Stujenske, Joseph Matthew

Related research

Other NIH-funded projects on the same topics.

  • Ketamine to boost fear extinction and memory on PTSD patients

    A study testing whether ketamine can help people with PTSD better relearn and forget fear when given in a guided treatment plan.

    NIH research Yale University · New Haven, United States · NIH-11592530

  • Metabolic effects of PFAS exposure in the Cape Fear Basin (GenX Exposure Study)

    This NIH grant studies how PFAS chemicals in drinking water may affect metabolism and weight-related health in adults and children living along the Cape Fear River.

    NIH research North Carolina State University Raleigh · Raleigh, United States · NIH-11541905

  • Inflammation and fear learning in PTSD

    This study looks at how a temporary inflammatory challenge affects fear extinction in people with and without PTSD to better understand how PTSD could be treated.

    NIH research Northern California Institute/res/edu · San Francisco, United States · NIH-11468318

  • Sleep-based brain wiring of fear memory in the amygdala

    A study in people or animals will look at how sleep helps the amygdala store fear memories by using advanced brain imaging and genetic tools to understand memory changes.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11456018

  • Understanding and improving fear and safety learning in OCD

    A study at Yale will test brain-based methods to help adults with OCD improve safety learning and fear extinction during therapy.

    NIH research Yale University · New Haven, United States · NIH-11415686

  • Targeting Vasopressin and Oxytocin Receptors to Treat Anxiety and Fear

    Researchers are testing how brain chemical signals related to vasopressin and oxytocin in the BNST region affect fear and anxiety, with the goal of identifying new ways to treat anxiety disorders.

    NIH research Rosalind Franklin Univ of Medicine & Sci · North Chicago, United States · NIH-11408439

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.